[Chorioretinal scarring after radiotherapy of malignant choroidal melanoma with the ruthenium 106 applicator].
A patient with a malignant melanoma of the choroid was treated at first successfully with the 106Ru beta ray applicator. Because new tumor growth could not be ruled out, the eye was enucleated 2 1/2 years after radiotherapy. The histopathologic examination revealed, however, a complete tumor cell necrosis.
D002830:Choroid Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008875:Middle Aged; D011868:Radioisotopes / Q000627:therapeutic use*; D012428:Ruthenium / Q000627:therapeutic use*
D011868:Radioisotopes; D012428:Ruthenium
Netzhaut-Aderhautnarbe nach Bestrahlung eines malignen Melanoms der Aderhaut mit dem Ruthenium-106-Applikator.